Related content

Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke Patients Receiving Thrombectomy: Standard or Low Dose Therapy?

By  

Current Neurovascular Research, Vol. 15, Iss. 3, 2018-08 ,pp. : 204-210

Bentham Science Publishers

Access to resources Recommend Favorite

Can baseline magnetic resonance angiography (MRA) status become a foremost factor in selecting optimal acute stroke patients for recombinant tissue plasminogen activator (rt-PA) thrombolysis beyond 3 hours?

By Ma Li   Gao Pei-Yi   Lin Yan   Xue Jing   Wang Xiao-Chun   Wang Yong-Jun   Wang Yi-Long   Liao Xiao-Ling   Liu Mei-Li   Cui Shi-Ming   Yu Lan   Tong Sui-Jun   Huang Yuan-Liang   Zhou Yu-Ming  

Neurological Research, Vol. 31, Iss. 4, 2009-05 ,pp. : 355-361

Maney Publishing

Access to resources Recommend Favorite

Thrombolysis with alteplase for acute ischemic stroke patients with atrial fibrillation

By Zhang Jing-Bo   Ding Ze-Yu   Yang Ying   Sun Wei   Hai Feng   Sui Xin-Ning   Li Xue-Yuan   Wang Hong-Zhi   Wang Xin-Tao   Zheng Jin-Lian  

Neurological Research, Vol. 32, Iss. 4, 2010-05 ,pp. : 353-358

Maney Publishing

Access to resources Recommend Favorite

Chinese neurologists’ perspective on intravenous thrombolysis for acute ischemic stroke

By  

Brain And Behavior, Vol. 8, Iss. 1, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of Cardioembolic Etiology on Intravenous Thrombolysis Efficacy for Acute Ischemic Stroke

By  

Current Neurovascular Research, Vol. 13, Iss. 3, 2016-06 ,pp. : 193-198

Bentham Science Publishers

Access to resources Recommend Favorite